scholarly journals UNUSUAL CASE OF RETROPHARYNGEAL HEMATOMA WITH USE OF ORAL ANTICOAGULANT THERAPY – CASE REPORT AND REVIEW OF LITERATURE

2020 ◽  
Vol VOLUME 8 (ISSUE 2) ◽  
pp. 43-48
Author(s):  
Srujan Vallur

Abstract Retropharyngeal space is a rare site of spontaneous haemorrhage and the formation of a hematoma in this location is a rarer complication of therapy with anticoagulants. Airway compromise can occur in rapidly increasing retropharyngeal hematoma. Emergent airway stabilisation is the key to a successful management of such cases, apart from reversal of causative factor. W e r e p o r t a c a s e o f s p o n t a n e o u s retropharyngeal hematoma in an elderly female on anticoagulant therapy for Rheumatic heart disease, and has developed rapidly progressive swelling in neck, post bout of violent cough. She was successfully managed with emergent airway access and reversal of causative factors. Keywords: Retropharyngeal hematoma, Retropharyngeal space, Anticoagulant therapy

1977 ◽  
Vol 37 (02) ◽  
pp. 222-232 ◽  
Author(s):  
D. A Tibbutt ◽  
C. N Chesterman ◽  
E. W Williams ◽  
T Faulkner ◽  
A. A Sharp

SummaryTreatment with streptokinase (‘Kabikinase’) was given to 26 patients with venographically confirmed deep vein thrombosis extending into the popliteal vein or above. Treatment was continued for 4 days and the patients were allocated randomly to oral anticoagulant therapy or a course of treatment with ancrod (‘Arvin’) for 6 days followed by oral anticoagulant therapy. The degree of thrombolysis as judged by further venographic examination at 10 days was not significantly different between the 2 groups. The majority of patients showed clinical improvement but there was no appreciable difference between the groups at 3 and 6 months. Haemorrhagic complications were a more serious problem during the period of treatment with ancrod than during the equivalent period in the control group.


1992 ◽  
Vol 68 (02) ◽  
pp. 160-164 ◽  
Author(s):  
P J Braun ◽  
K M Szewczyk

SummaryPlasma levels of total prothrombin and fully-carboxylated (native) prothrombin were compared with results of prothrombin time (PT) assays for patients undergoing oral anticoagulant therapy. Mean concentrations of total and native prothrombin in non-anticoagulated patients were 119 ± 13 µg/ml and 118 ± 22 µg/ml, respectively. In anticoagulated patients, INR values ranged as high as 9, and levels of total prothrombin and native prothrombin decreased with increasing INR to minimum values of 40 µg/ml and 5 µg/ml, respectively. Des-carboxy-prothrombin increased with INR, to a maximum of 60 µg/ml. The strongest correlation was observed between native prothrombin and the reciprocal of the INR (1/INR) (r = 0.89, slope = 122 µg/ml, n = 200). These results indicated that native prothrombin varied over a wider range and was more closely related to INR values than either total or des-carboxy-prothrombin. Levels of native prothrombin were decreased 2-fold from normal levels at INR = 2, indicating that the native prothrombin antigen assay may be a sensitive method for monitoring low-dose oral anticoagulant therapy. The inverse relationship between concentration of native prothrombin and INR may help in identification of appropriate therapeutic ranges for oral anticoagulant therapy.


2001 ◽  
Vol 2 (3) ◽  
pp. 210-211 ◽  
Author(s):  
Emmanuel Gyan ◽  
Stéphane Darre ◽  
Brigitte Jude ◽  
Nathalie Cambier ◽  
Jean-Loup Demory ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document